237 related articles for article (PubMed ID: 22431919)
1. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
Kumbrink J; Kirsch KH
Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
[TBL] [Abstract][Full Text] [Related]
2. Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
Soni S; Lin BT; August A; Nicholson RI; Kirsch KH
J Cell Biochem; 2009 May; 107(2):364-75. PubMed ID: 19330798
[TBL] [Abstract][Full Text] [Related]
3. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
Brinkman A; van der Flier S; Kok EM; Dorssers LC
J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.
Kumbrink J; Soni S; Laumbacher B; Loesch B; Kirsch KH
J Biol Chem; 2015 May; 290(19):12247-55. PubMed ID: 25805500
[TBL] [Abstract][Full Text] [Related]
6. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.
Kumbrink J; Kirsch KH; Johnson JP
J Cell Biochem; 2010 Sep; 111(1):207-17. PubMed ID: 20506119
[TBL] [Abstract][Full Text] [Related]
7. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
9. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
[TBL] [Abstract][Full Text] [Related]
10. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
[TBL] [Abstract][Full Text] [Related]
11. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
12. GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1.
Marks BA; Pipia IM; Mukai C; Horibata S; Rice EJ; Danko CG; Coonrod SA
BMC Cancer; 2023 Feb; 23(1):138. PubMed ID: 36765275
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells.
Ghalehno AD; Abdi H; Boustan A; Jamialahmadi K; Mosaffa F
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3723-3732. PubMed ID: 37310508
[TBL] [Abstract][Full Text] [Related]
14. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
Riggins RB; Thomas KS; Ta HQ; Wen J; Davis RJ; Schuh NR; Donelan SS; Owen KA; Gibson MA; Shupnik MA; Silva CM; Parsons SJ; Clarke R; Bouton AH
Cancer Res; 2006 Jul; 66(14):7007-15. PubMed ID: 16849545
[TBL] [Abstract][Full Text] [Related]
15. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
16. A bi-stable feedback loop between GDNF, EGR1, and ERĪ± contribute to endocrine resistant breast cancer.
Horibata S; Rice EJ; Zheng H; Mukai C; Chu T; Marks BA; Coonrod SA; Danko CG
PLoS One; 2018; 13(4):e0194522. PubMed ID: 29614078
[TBL] [Abstract][Full Text] [Related]
17. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
[TBL] [Abstract][Full Text] [Related]
18. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
Godinho M; Meijer D; Setyono-Han B; Dorssers LC; van Agthoven T
J Cell Physiol; 2011 Jul; 226(7):1741-9. PubMed ID: 21506106
[TBL] [Abstract][Full Text] [Related]
19. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor.
Gotoh T; Cai D; Tian X; Feig LA; Lerner A
J Biol Chem; 2000 Sep; 275(39):30118-23. PubMed ID: 10896938
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
